
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Danish Cancer Society, Institute of Cancer Epidemiology, DK-2100 Copenhagen Ø, Denmark [S. K. K.]; Laboratory of Cellular Oncology, NIH, Bethesda, Maryland [B. C., J. T. S., D. R. L.]; Department of Pathology, Section of Molecular Pathology, University Hospital Vrije Universiteit, Amsterdam, the Netherlands [A. J. C. v. d. B., J. M. M. W., C. L. M. M.]; Department of Gynecology, Gentofte Hospital, Denmark [E. I. S.]; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia [G. P.]; Department of Gynecology, Rigshospitalet, Copenhagen, Denmark [J. E. B.]; and Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland [M. E. S.]
Genital human papillomavirus (HPV) infection is generally considered to be sexually transmitted. However, nonsexual spread of the virus has also been suggested. The goal of this study was to assess: (a) the role of sexual intercourse in the transmission of HPV; (b) the determinants for seroconversion; and (c) the correlation between HPV DNA, abnormal cervical cytology, and serological response to HPV16.
One hundred virgins and 105 monogamous women were randomly selected from a population-based cohort study in Copenhagen, Denmark, in which the women were examined twice with 2-year interval (interview, cervical swabs, Pap smear, blood samples). The presence of HPV DNA was determined by GP5+/6+ primers based HPV-PCR-EIA. HPV 16 virus-like particles (VLP) antibodies were detected by ELISA.
All of the virgins were both HPV DNA negative and seronegative to VLP16, except for one woman who was weakly HPV 6 DNA positive. Only those virgins who initiated sexual activity became HPV DNA positive and/or VLP16 positive. The most important determinant of HPV DNA acquisition was the number of partners between the two examinations. The only significant risk factor for HPV 16 VLP seroconversion among women acquiring HPV DNA was HPV type.
Our results show that sexual intercourse is important in the transmission of HPV, and that HPV 16 VLP seroconversion and the development of cervical lesions only occur after HPV transmission. Remarkably, no cervical lesions were found in HPV 16 DNA positive women who had seroconverted. Although based on small numbers, this may suggest that the development of antibodies had a protective effect.
This article has been cited by other articles:
![]() |
J. Koshiol, L. Lindsay, J. M. Pimenta, C. Poole, D. Jenkins, and J. S. Smith Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis Am. J. Epidemiol., July 15, 2008; 168(2): 123 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ji, A. S. Neumann, E. M. Sturgis, K. Adler-Storthz, K. R. Dahlstrom, J. T. Schiller, Q. Wei, and G. Li p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers Carcinogenesis, April 1, 2008; 29(4): 875 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Sjo, C. von Buchwald, P. Cassonnet, B. Norrild, J. U. Prause, T. Vinding, and S. Heegaard Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: types and frequencies in a large series Br. J. Ophthalmol., August 1, 2007; 91(8): 1014 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
N W J Bulkmans, S Bulk, M S Ottevanger, L Rozendaal, S M Hellenberg, F J van Kemenade, P J F Snijders, A J P Boeke, and C J L M Meijer Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate J. Clin. Pathol., November 1, 2006; 59(11): 1218 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Jayasinghe and S M Garland Genital warts in children: what do they mean? Arch. Dis. Child., August 1, 2006; 91(8): 696 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fakhry and M. L. Gillison Clinical Implications of Human Papillomavirus in Head and Neck Cancers J. Clin. Oncol., June 10, 2006; 24(17): 2606 - 2611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vaccarella, S. Franceschi, R. Herrero, N. Munoz, P. J.F. Snijders, G. M. Clifford, J. S. Smith, E. Lazcano-Ponce, S. Sukvirach, H.-R. Shin, et al. Sexual Behavior, Condom Use, and Human Papillomavirus: Pooled Analysis of the IARC Human Papillomavirus Prevalence Surveys. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 326 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Sawaya A 21-Year-Old Woman With Atypical Squamous Cells of Undetermined Significance JAMA, November 2, 2005; 294(17): 2210 - 2218. [Full Text] [PDF] |
||||
![]() |
A G Bais, I Beckmann, J Lindemans, P C Ewing, C J L M Meijer, P J F Snijders, and T J M Helmerhorst A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions J. Clin. Pathol., October 1, 2005; 58(10): 1096 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kjaer, C. Munk, J. Falck Winther, H. O. Jorgensen, C. J.L.M. Meijer, and A. J.C. van den Brule Acquisition and Persistence of Human Papillomavirus Infection in Younger Men: A Prospective Follow-up Study among Danish Soldiers Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1528 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Goldie, J. J. Kim, and T. C. Wright Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More Obstet. Gynecol., April 1, 2004; 103(4): 619 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. X. Bosch and S. de Sanjose Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 3 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schiffman and S. K. Kjaer Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 14 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
F X Bosch, A Lorincz, N Munoz, C J L M Meijer, and K V Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol., April 1, 2002; 55(4): 244 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Touze, S. de Sanjose, P. Coursaget, M. R. Almirall, V. Palacio, C. J. L. M. Meijer, J. Kornegay, and F. X. Bosch Prevalence of Anti-Human Papillomavirus Type 16, 18, 31, and 58 Virus-Like Particles in Women in the General Population and in Prostitutes J. Clin. Microbiol., December 1, 2001; 39(12): 4344 - 4348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |